Lucie Etienne-Mesmin1, Benoit Chassaing1, Oluwaseyi Adekunle2, Lisa M Mattei3, Frederic D Bushman4, Andrew T Gewirtz1. 1. Center for Inflammation Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia, USA. 2. Immunology and Molecular Pathogenesis Graduate Program, Emory University, Atlanta, Georgia, USA. 3. PennCHOP Microbiome, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. 4. Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Abstract
OBJECTIVE: Clostridium difficile is a toxin-producing bacterium and a leading cause of antibiotic-associated disease. The ability of C. difficile to form spores and infect antibiotic-treated persons at low multiplicity of infection (MOI) underlies its large disease burden. However, C. difficile-induced disease might also result from long-harboured C. difficile that blooms in individuals administered antibiotics. DESIGN: Mice purchased from multiple vendors and repeatedly testing negative for this pathogen by quantitative PCR bloomed C. difficile following antibiotic treatment. This endogenous C. difficile strain, herein termed LEM1, which formed spores and produced toxin, was compared with highly pathogenic C. difficile strain VPI10463. RESULTS: Whole-genome sequencing revealed that LEM1 and VPI10463 shared 95% of their genes, including all known virulence genes. In contrast to VPI10463, LEM1 did not induce overt disease when administered to antibiotic-treated or germ-free mice, even at high doses. Rather, blooms of LEM1 correlated with survival following VPI10463 inoculation, and exogenous administration of LEM1 before or shortly following VPI10463 inoculation prevented C. difficile-induced death. Accordingly, despite similar growth properties in vitro, LEM1 strongly outcompeted VPI10463 in mice even at 100-fold lower inocula. CONCLUSIONS: These results highlight the difficulty of determining whether individual cases of C. difficile infection resulted from a bloom of endogenous C. difficile or a new exposure to this pathogen. In addition to impacting the design of studies using mouse models of C. difficile-induced disease, this study identified, isolated and characterised an endogenous murine spore-forming C. difficile strain able to decrease colonisation, associated disease and death induced by a pathogenic C. difficile strain. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
OBJECTIVE:Clostridium difficile is a toxin-producing bacterium and a leading cause of antibiotic-associated disease. The ability of C. difficile to form spores and infect antibiotic-treated persons at low multiplicity of infection (MOI) underlies its large disease burden. However, C. difficile-induced disease might also result from long-harboured C. difficile that blooms in individuals administered antibiotics. DESIGN:Mice purchased from multiple vendors and repeatedly testing negative for this pathogen by quantitative PCR bloomed C. difficile following antibiotic treatment. This endogenous C. difficile strain, herein termed LEM1, which formed spores and produced toxin, was compared with highly pathogenic C. difficile strain VPI10463. RESULTS: Whole-genome sequencing revealed that LEM1 and VPI10463 shared 95% of their genes, including all known virulence genes. In contrast to VPI10463, LEM1 did not induce overt disease when administered to antibiotic-treated or germ-free mice, even at high doses. Rather, blooms of LEM1 correlated with survival following VPI10463 inoculation, and exogenous administration of LEM1 before or shortly following VPI10463 inoculation prevented C. difficile-induced death. Accordingly, despite similar growth properties in vitro, LEM1 strongly outcompeted VPI10463 in mice even at 100-fold lower inocula. CONCLUSIONS: These results highlight the difficulty of determining whether individual cases of C. difficileinfection resulted from a bloom of endogenous C. difficile or a new exposure to this pathogen. In addition to impacting the design of studies using mouse models of C. difficile-induced disease, this study identified, isolated and characterised an endogenous murine spore-forming C. difficile strain able to decrease colonisation, associated disease and death induced by a pathogenic C. difficile strain. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Authors: Martin Krzywinski; Jacqueline Schein; Inanç Birol; Joseph Connors; Randy Gascoyne; Doug Horsman; Steven J Jones; Marco A Marra Journal: Genome Res Date: 2009-06-18 Impact factor: 9.043
Authors: Kristin J Nagaro; S Tyler Phillips; Adam K Cheknis; Susan P Sambol; Walter E Zukowski; Stuart Johnson; Dale N Gerding Journal: Antimicrob Agents Chemother Date: 2013-08-12 Impact factor: 5.191
Authors: Anthony M Buckley; Janice Spencer; Lindsay M Maclellan; Denise Candlish; June J Irvine; Gillian R Douce Journal: PLoS One Date: 2013-05-21 Impact factor: 3.240
Authors: Michael S M Brouwer; Adam P Roberts; Haitham Hussain; Rachel J Williams; Elaine Allan; Peter Mullany Journal: Nat Commun Date: 2013 Impact factor: 14.919
Authors: Ross Overbeek; Robert Olson; Gordon D Pusch; Gary J Olsen; James J Davis; Terry Disz; Robert A Edwards; Svetlana Gerdes; Bruce Parrello; Maulik Shukla; Veronika Vonstein; Alice R Wattam; Fangfang Xia; Rick Stevens Journal: Nucleic Acids Res Date: 2013-11-29 Impact factor: 16.971
Authors: Kathleen G L Ma; Kvin Lertpiriyapong; Alessandra Piersigilli; Irina Dobtsis; Juliette R K Wipf; Eric R Littmann; Ingrid Leiner; Eric G Pamer; Rodolfo J Ricart Arbona; Neil S Lipman Journal: Comp Med Date: 2020-05-13 Impact factor: 0.982
Authors: Lucie Etienne-Mesmin; Benoit Chassaing; Oluwaseyi Adekunle; Lisa M Mattei; Adrianne N Edwards; Shonna M McBride; Frederic D Bushman; Andrew T Gewirtz Journal: Genome Announc Date: 2017-04-06
Authors: Theresa Mau; Samantha S Eckley; Ingrid L Bergin; Katie Saund; Jason S Villano; Kimberly C Vendrov; Evan S Snitkin; Vincent B Young; Raymond Yung Journal: mSphere Date: 2019-03-20 Impact factor: 4.389
Authors: Ilse M Boekhoud; Bastian V H Hornung; Eloisa Sevilla; Céline Harmanus; Ingrid M J G Bos-Sanders; Elisabeth M Terveer; Rosa Bolea; Jeroen Corver; Ed J Kuijper; Wiep Klaas Smits Journal: Nat Commun Date: 2020-01-30 Impact factor: 14.919
Authors: Felix Broecker; Erik Wegner; Bruna M S Seco; Paulina Kaplonek; Maria Bräutigam; Armin Ensser; Frederick Pfister; Christoph Daniel; Christopher E Martin; Jochen Mattner; Peter H Seeberger Journal: ACS Chem Biol Date: 2019-11-19 Impact factor: 5.100
Authors: Jeffrey R Maslanka; Christopher H Gu; Isma Zarin; Joshua E Denny; Susan Broadaway; Bryton Fett; Lisa M Mattei; Seth T Walk; Michael C Abt Journal: Gut Microbes Date: 2020-11-09
Authors: Jhansi L Leslie; Matthew L Jenior; Kimberly C Vendrov; Alexandra K Standke; Madeline R Barron; Tricia J O'Brien; Lavinia Unverdorben; Pariyamon Thaprawat; Ingrid L Bergin; Patrick D Schloss; Vincent B Young Journal: mBio Date: 2021-03-30 Impact factor: 7.867